For sales

📢Highlights from the Week of 19th January – 26th January in the world of pharma and healthcare! 🗞️👀 

Highlights from the week of 19 January - 26 January Ionis Pharmaceuticals ( EU, Approval ) European Commission approves Ionis and Otsuka's DAWNZERA for the prevention of recurrent hereditary angioedema attacks in patients aged 12 years and older GSK ( EU, Approval ) GSK’s vaccine, AREXVY, receives European Commission approval for expanded use in adults aged 18 years and older to prevent lower respiratory tract disease caused by RSV GSK ( NMPA, Approval ) NMPA approves GSK's TRELEGY ELLIPTA as the first and only single inhaler triple therapy for the maintenance treatment of both asthma and chronic obstructive pulmonary disease in adults Akesobio ( NMPA, Approval ) Akeso gains NMPA approval for its sNDA AK-111, a monoclonal antibody, to treat active ankylosing spondylitis All logos and trademarks remain the intellectual properties of their respective owners
Download

Connect with us

Please fill in the information below, and we'll get back to you.